| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08e0f33a5ccb36cde52cac90e80bf240 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate |
2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4594b44c53cba3327f6fed1e0416303c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cbd8976daa8c6e221703e361b6c7c37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_062d52c05eb048fb6ae59a33f47f367e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93bfe49c869d5f948800a1760be66767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_371f73430692af42bc3c7cd8eb1032e1 |
| publicationDate |
2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014160079-A1 |
| titleOfInvention |
Microemulsion topical delivery platform |
| abstract |
Provided are pharmaceutical carriers suitable based on oil-in- water microemulsions and methods of making same. Also provided are pharmaceutical compositions comprising a carrier of the invention and a lipophilic active pharmaceutical ingredient (API), as well as methods for making same. The pharmaceutical compositions are particularly suitable for use in formulating lipophilic APIs for topical administration to the eye. Specifically included are pharmaceutical compositions comprising fenofibrate or fenofibric acid as API. Also provided is a method of treating a disease of the posterior segment of the eye. Also provided is a pharmaceutical composition comprising a compound represented by (Formula I) formulated for topical administration to the eye. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10660848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018512452-A |
| priorityDate |
2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |